Cargando…
Efficacy of early use of remdesivir: a systematic review of subgroup analysis
INTRODUCTION: A possible benefit has been suggested for early treatment of severe coronavirus disease 2019 (COVID-19) with remdesivir. The efficacy of this drug is controversial and could significantly influence the efficiency in healthcare systems. The objective is the methodological interpretation...
Autores principales: | Gil-Sierra, Manuel David, BriceñoCasado, Maria del Pilar, Rey, Emilio Jesús Alegre-Del, Sánchez-Hidalgo, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134888/ https://www.ncbi.nlm.nih.gov/pubmed/35294145 http://dx.doi.org/10.37201/req/154.2021 |
Ejemplares similares
-
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022) -
Long-lasting effect of belantamab mafodotin in heavily pretreated multiple myeloma
por: Gil-Sierra, Manuel David, et al.
Publicado: (2022) -
Concerns about subgroup analyses and reason for stopping remdesivir trial
por: Vijayaraghavan, Bharath Kumar Tirupakuzhi
Publicado: (2022) -
Association between Social Support and Depressive Symptoms in Informal Caregivers of Adult and Older Dependents: A Systematic Review and Meta-Analysis
por: Gutiérrez-Sánchez, Belén, et al.
Publicado: (2023) -
Efficacy of Conservative Therapy in Overhead Athletes with Glenohumeral Internal Rotation Deficit: A Systematic Review and Meta-Analysis
por: Jiménez-del-Barrio, Sandra, et al.
Publicado: (2022)